Conventional liposomes, composed of phospholipid bilayers, are biocompatible, can encapsulate both hydrophilic and lipophilic drugs, and protect therapeutics from enzymatic degradation, making them suitable for delivering insulin, curcumin, silibinin, or lycopene in diabetes, obesity, and NAFLD. This evidence concerns the gene INS and obesity disorder.